Thomas J. Farrell serves as Executive at BELLICUM PHARMACEUTICALS, INC, where they oversee executive responsibilities. Since joining the company, Thomas J. Farrell has executed 6 insider transactions totaling $129.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 1, 2015 involved selling 2,500 shares valued at $36.5K.
Thomas J. Farrell currently holds 63,862 shares of BELLICUM PHARMACEUTICALS, INC (BLCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas J. Farrell has been a net seller of BLCM stock. They have purchased $0 and sold $129.0K worth of shares.
Thomas J. Farrell's most recent insider trade was on Oct 1, 2015, when they sold 2,500 shares at $14.58 per share.
Get notified when new Form 4 filings are submitted
| $16.78 |
| Discretionary |
| Aug 3, 2015 | BLCM | $50.6K | Sale | 2,500 | $20.24 | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Other | 607 | $N/A | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Conversion | 12,718 | $N/A | Discretionary |
| Dec 23, 2014 | BLCM | $0 | Conversion | 4,451 | $N/A | Discretionary |